Data as of Jan 23
 -0.14 / -3.08%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.

Contact Information

QLT, Inc.
887 Great Northern Way
Vancouver British Columbia V5T 4T5
P:(604) 707-7000
Investor Relations:



Mutual fund holders9.79%
Other institutional62.60%
Individual stakeholders45.82%

Top Executives

Geoffrey F. CoxChief Executive Officer & Independent Director
Sukhi JagpalChief Financial Officer
Sushanta MallickVice President-Research & Development
Glen IbbottVice President-Finance

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.